Advanced search
Start date

Impairment of postprandial GLP-1 bioavailability and renal GLP-1R activation in experimental hypertension: role of salt consumption

Grant number: 22/15827-7
Support Opportunities:Scholarships in Brazil - Scientific Initiation
Effective date (Start): February 01, 2023
Effective date (End): July 31, 2023
Field of knowledge:Biological Sciences - Physiology - Physiology of Organs and Systems
Principal Investigator:Adriana Castello Costa Girardi
Grantee:Victória Cavalcante Sousa
Host Institution: Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Associated research grant:21/14534-3 - Pleiotropic effects of antidiabetic agents and their pharmacological targets: renoprotective mechanisms beyond glycemic control, AP.TEM


Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L cells whose primary function involves the maintenance of glycemic homeostasis. However, different studies have consistently demonstrated that GLP-1 receptor (GLP-1R) agonists, drugs used to treat type 2 diabetes mellitus, exert several extraglycemic effects, including increased diuresis and natriuresis and reduced blood pressure (BP) in non-diabetic hypertensive models and patients. Additionally, it has been demonstrated that the acute blockade of GLP-1R through the systemic infusion of the antagonist exendin-9 exerts antinatriuretic and antidiuretic effects in rats. Accordingly, the long-term blockade of this receptor raises blood pressure levels in normotensive and hypertensive rats. Based on these observations, we postulated that GLP-1 might also protect against excessive salt ingested in the diet and that the postprandial levels of this incretin would be reduced in hypertensive individuals, resulting in less activation of the GLP-1R located in the kidneys, increasing fluid and sodium retention, thus contributing in increased BP. Therefore, this project aims to test the hypothesis that the postprandial GLP-1 bioavailability is impaired, renal GLP-1R activation is reduced in hypertension, and salt consumption aggravates this pathophysiological process. To this end, spontaneously hypertensive and normotensive male rats will receive diets containing low, average, and high sodium concentrations for one month. For the analysis of gene and protein expression of GLP-1R, pro-convertase-1/3, and pro-glucagon, kidneys and intestines will be collected for quantitative PCR and immunoblotting assays. For evaluation of intact, total GLP-1 and insulin, blood will be collected under fasting and postprandial conditions. Additionally, urine will be collected for cAMP analysis. The results obtained through this project may provide a better understanding of salt sensitivity mechanisms and the role of GLP-1 in the pathophysiology of arterial hypertension.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.